10
Participants
Start Date
February 1, 2021
Primary Completion Date
December 1, 2021
Study Completion Date
December 1, 2021
cannabidiol extract
"The test article CBD Cannabis Extract Oral Solution will be manufactured by the University of Mississippi National Center for Natural Products Research (NCNPR) at the Coy Waller Laboratory under FDA Current Good Manufacturing Practices. The drug product, derived from hemp and containing less than 0.3% of Δ9-tetrahydrocannabinol, is no longer a Drug Enforcement Agency (DEA) controlled substance. DEA registrations are not required for the manufacturing, handling or dispensing of these clinical test materials"
University of Mississippi, University
University of Mississippi, Oxford
OTHER